Thai law: FDA to allow private medical cannabis production
HempMarijuana Industry News July 4, 2020 MJ Shareholders 0
Reopening its cannabis regulatory platform after months of disruption caused by the coronavirus, the Food and Drug Administration has prepared a draft bill to abolish a 5-year ban on the private sector making cannabis medicine.
Two draft ministerial regulations, one on marijuana and the other on hemp, under scrutiny since the end of last year and January respectively by the Council of State—the government’s legal arm—are also inching ahead following the easing of the lockdown.
Under these three pieces of legislation and regulations, foreigners will be allowed to get involved as long as they hold shares not exceeding one-third in a company incorporated under local law.
International travelers are the most relaxed category and are always eligible to apply for import and export licenses to bring in and take out cannabis medicine to treat their illnesses.
The Ban
The present cannabis law sets out qualifications of an applicant for a production, import or export license to be limited only to state agencies or state-agency backed farmer groups and private universities.
Non-state entities are not eligible to apply. [read more @ Khaosod English]
MJ Shareholders
MJShareholders.com is the largest dedicated financial network and leading corporate communications firm serving the legal cannabis industry. Our network aims to connect public marijuana companies with these focused cannabis audiences across the US and Canada that are critical for growth: Short and long term cannabis investors Active funding sources Mainstream media Business leaders Cannabis consumers
No comments so far.
Be first to leave comment below.